Macquarie Group LTD Axsome Therapeutics, Inc. Transaction History

Macquarie Group LTD

  • $86.4 Billion
  • Q4 2024

A detailed history of Macquarie Group LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 964,047 shares of AXSM stock, worth $133 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
964,047
Previous 995,287 3.14%
Holding current value
$133 Million
Previous $89.4 Million 8.79%
% of portfolio
0.09%
Previous 0.1%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$83.08 - $100.49 $2.6 Million - $3.14 Million
-31,240 Reduced 3.14%
964,047 $81.6 Million
Q3 2024

Nov 14, 2024
SELL
$78.93 - $95.84 $6.15 Million - $7.47 Million
-77,955 Reduced 7.26%
995,287 $89.4 Million
Q2 2024

Aug 09, 2024
BUY
$65.72 - $80.5 $24.5 Million - $30 Million
372,832 Added 53.23%
1,073,242 $86.4 Million
Q1 2024

May 14, 2024
BUY
$69.39 - $97.64 $46.7 Million - $65.7 Million
672,886 Added 2444.72%
700,410 $55.9 Million
Q4 2023

Feb 14, 2024
BUY
$57.42 - $83.61 $345,036 - $502,412
6,009 Added 27.93%
27,524 $2.19 Million
Q3 2023

Nov 14, 2023
SELL
$69.25 - $82.21 $1.7 Million - $2.02 Million
-24,576 Reduced 53.32%
21,515 $1.5 Million
Q2 2023

Aug 14, 2023
BUY
$58.41 - $90.35 $1.53 Million - $2.37 Million
26,187 Added 131.57%
46,091 $3.31 Million
Q1 2023

May 15, 2023
BUY
$58.39 - $75.0 $87,468 - $112,350
1,498 Added 8.14%
19,904 $1.23 Million
Q4 2022

Feb 21, 2023
SELL
$39.94 - $79.72 $371,481 - $741,475
-9,301 Reduced 33.57%
18,406 $1.42 Million
Q3 2022

Nov 14, 2022
SELL
$36.06 - $69.85 $235,111 - $455,421
-6,520 Reduced 19.05%
27,707 $1.24 Million
Q2 2022

Aug 15, 2022
SELL
$21.74 - $46.75 $109,721 - $235,947
-5,047 Reduced 12.85%
34,227 $1.31 Million
Q1 2022

May 16, 2022
BUY
$23.7 - $41.39 $307,507 - $537,035
12,975 Added 49.34%
39,274 $1.63 Million
Q4 2021

Feb 11, 2022
BUY
$30.7 - $43.36 $1,657 - $2,341
54 Added 0.21%
26,299 $994,000
Q3 2021

Nov 12, 2021
BUY
$19.91 - $68.26 $32,015 - $109,762
1,608 Added 6.53%
26,245 $865,000
Q2 2021

Aug 13, 2021
BUY
$50.63 - $73.5 $149,155 - $216,531
2,946 Added 13.58%
24,637 $1.66 Million
Q1 2021

May 14, 2021
BUY
$55.91 - $81.44 $153,808 - $224,041
2,751 Added 14.52%
21,691 $1.23 Million
Q4 2020

Feb 16, 2021
BUY
$66.31 - $86.52 $1.18 Million - $1.54 Million
17,772 Added 1521.58%
18,940 $1.54 Million
Q2 2020

Aug 11, 2020
BUY
$49.87 - $98.69 $58,248 - $115,269
1,168 New
1,168 $96,000

Others Institutions Holding AXSM

# of Institutions
351
Shares Held
36.3M
Call Options Held
1.77M
Put Options Held
1.16M
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $5.91B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email